Using Monoclonal Antibodies to Detect Bone Marrow Metastases in Small Cell Lung Cancer
Author Information
Author(s): B.G. Skovl, F.R. Hirsch, L. Bobrow
Hypothesis
Can monoclonal antibodies improve the detection of bone marrow metastases in patients with small cell lung cancer compared to conventional examination?
Conclusion
Monoclonal antibodies may be useful for diagnosing bone marrow infiltration when conventional examination suggests suspicious infiltration, but they cannot detect metastatic tumor cells when conventional examination shows no tumor cells.
Supporting Evidence
- Conventional examination detected metastases in approximately 25% of patients with small cell lung cancer.
- Monoclonal antibodies were positive in 60-90% of slides with infiltrating tumor cells in patients where metastases were detected by conventional examination.
- No positive tumor cells were detected in patients where conventional examination did not reveal any tumor cells.
Takeaway
Doctors used special antibodies to look for cancer cells in the bone marrow of lung cancer patients, but they found that these antibodies didn't help find cancer when the regular tests showed no cancer cells.
Methodology
The study involved examining bone marrow samples from patients with small cell lung cancer using a panel of monoclonal antibodies and comparing the results with conventional examination.
Limitations
The antibodies failed to detect metastatic tumor cells in bone marrow sections where conventional examination did not reveal any tumor cells.
Participant Demographics
Patients included 218 with small cell lung cancer and 20 with non-malignant diseases.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website